Subramaniam Sriram

Subramaniam Sriram, operating as a sole proprietorship from Nashville, Tennessee, provides medical expert services and independent medical case reviews for the Vaccine Injury Compensation Program (VICP) and Countermeasures Injury Compensation Program (CICP) as a prime contractor exclusively to the Department of Health and Human Services Health Resources and Services Administration. Sriram is a self-certified small disadvantaged business competing predominantly under total small business set-asides on individual BPA calls, though his most recent single-award BPA vehicle carries no set-aside designation.

Sriram's capability portfolio consists entirely of specialized medical expert services: independent medical case reviews, expert medical analyses, expert witness consultation, and advisory services for vaccine injury compensation claims filed under the federal no-fault VICP and CICP. Representative recent work includes a $24,375 BPA call awarded August 10, 2026, for medical case reviewer services under the VICP; an $11,250 BPA call awarded September 22, 2026, for the same service; and a $3,750 BPA call awarded March 4, 2026, set aside for total small business participation. Earlier awards in the portfolio range from $1,200 to $18,750 per call, all directed at individual vaccine injury compensation case evaluation.

Customer concentration is absolute: 100% of Sriram's 248 prime awards, representing $20.9 million in combined potential value, fund HHS HRSA programs. HRSA has issued approximately 90 task orders to Sriram under his active BPA portfolio since July 2019, reflecting consistent reliance on his medical expertise for VICP and CICP adjudication. Sriram sits on five active blanket purchase agreements with HRSA, the largest being Blanket Purchase Agreement HHSH250201400072B (88 task orders, $300 thousand combined potential value), Blanket Purchase Agreement HHSH234200851032B (71 task orders, $166 thousand), and Blanket Purchase Agreement 75R60221A00026 (40 task orders, $238 thousand). On May 18, 2026, HRSA awarded Sriram a new single-award BPA ceiling of $7.5 million running through May 17, 2031, representing the largest IDV vehicle in his portfolio and signaling expanded utilization of his services for vaccine injury compensation support.

Award activity has remained flat to modestly declining in recent years—nine awards in 2022, ten in 2023, eleven in 2024, then one in 2025 and four year-to-date in 2026. Only three awards (combined potential value $39 thousand) reach ultimate completion within the next twenty-four months, posing minimal recompete exposure. Sriram does not subcontract; he performs all work directly at his Nashville location. His categorization is 248 awards under NAICS 541511 (Offices of Physicians except Mental Health Specialists) and 231 awards under PSC Support—Professional: Expert Witness, reflecting the highly specialized nature of his federal footprint. Since first contracting with HRSA in October 2007, Sriram has maintained a single-customer, single-mission focus on vaccine injury program support, demonstrating deep domain expertise and long tenure in federal VICP administration.